
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $314.9M | -- | -- | -- | -- |
08/06/2025 | Q2 | $307.7M | -- | -- | -- | -- |
05/08/2025 | Q1 | $307.5M | $309.2M | $0.72 | $0.71 | $0.01 |
02/13/2025 | Q4 | $311.7M | $311.4M | $0.75 | $0.74 | $0.01 |
10/30/2024 | Q3 | $301.5M | $303.6M | $0.70 | $0.74 | -$0.04 |
08/01/2024 | Q2 | $292.3M | $296.1M | $1.32 | $0.71 | $0.61 |
05/02/2024 | Q1 | $288.1M | $291.3M | $0.66 | $0.69 | -$0.03 |
02/12/2024 | Q4 | $292.4M | $291.8M | $0.76 | $0.67 | $0.09 |
11/02/2023 | Q3 | $284.1M | $286.6M | $0.67 | $0.68 | -$0.01 |
08/02/2023 | Q2 | $276.3M | $280.7M | $0.72 | $0.65 | $0.07 |
05/04/2023 | Q1 | -- | $273.1M | $0.65 | -- | -- |
02/08/2023 | Q4 | -- | $280.1M | $1.40 | -- | -- |
11/03/2022 | Q3 | -- | $273.5M | $1.89 | -- | -- |
08/04/2022 | Q2 | -- | $264.1M | $0.75 | -- | -- |
05/05/2022 | Q1 | -- | $256.8M | $0.63 | -- | -- |
02/10/2022 | Q4 | -- | $254.2M | $1.44 | -- | -- |
11/04/2021 | Q3 | -- | $247.3M | $0.64 | -- | -- |
08/04/2021 | Q2 | -- | $231.6M | $0.57 | -- | -- |
05/05/2021 | Q1 | -- | $218.2M | $0.60 | -- | -- |
02/11/2021 | Q4 | -- | $219.5M | $1.22 | -- | -- |
11/06/2020 | Q3 | -- | $208.2M | -$0.41 | -- | -- |
08/05/2020 | Q2 | -- | $176.2M | $0.11 | -- | -- |
05/06/2020 | Q1 | -- | $231.6M | $0.70 | -- | -- |
02/10/2020 | Q4 | -- | $239.1M | $1.92 | -- | -- |
10/30/2019 | Q3 | -- | $233.9M | $0.84 | -- | -- |
08/01/2019 | Q2 | -- | $230.5M | $1.05 | -- | -- |
05/02/2019 | Q1 | -- | $232.2M | $0.78 | -- | -- |
02/13/2019 | Q4 | -- | $235.4M | $0.71 | -- | -- |
10/31/2018 | Q3 | -- | $229.8M | $0.82 | -- | -- |
08/01/2018 | Q2 | -- | $224.9M | $0.84 | -- | -- |
05/03/2018 | Q1 | -- | $225.4M | $0.81 | -- | -- |
02/13/2018 | Q4 | -- | $224M | $0.67 | -- | -- |
11/01/2017 | Q3 | -- | $218M | $1.47 | -- | -- |
08/02/2017 | Q2 | -- | $208M | $1.05 | -- | -- |
05/03/2017 | Q1 | -- | $207.4M | $0.78 | -- | -- |
02/13/2017 | Q4 | -- | $204.1M | $0.80 | -- | -- |
11/02/2016 | Q3 | -- | $201.2M | $0.82 | -- | -- |
08/05/2016 | Q2 | -- | $198M | $0.78 | -- | -- |
05/05/2016 | Q1 | -- | $198.3M | $1.10 | -- | -- |
02/10/2016 | Q4 | -- | $192.5M | $0.98 | -- | -- |
11/05/2015 | Q3 | -- | $185.3M | $0.75 | -- | -- |
Federal Realty Investment Trust reported $309.2M worth of top line sales in its most recent quarter.
Federal Realty Investment Trust announced earnings per share of $0.72 which represents a beat of analyst forecast a $0.71 per share.
Federal Realty Investment Trust reported $204.8M that represents $2.40 per share over the last quarter.
Federal Realty Investment Trust's earnings are forecast to decrease from $3.42 per share to $3.21 per share next year representing a decrease of -11.28%.
Federal Realty Investment Trust's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.